709 related articles for article (PubMed ID: 6317640)
1. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
Okamoto H; Yamamoto H
Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
[TBL] [Abstract][Full Text] [Related]
2. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
Okamoto H
Biomed Biochim Acta; 1985; 44(1):15-20. PubMed ID: 2986610
[No Abstract] [Full Text] [Related]
3. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H
Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889
[TBL] [Abstract][Full Text] [Related]
4. Streptozotocin and alloxan induce DNA strand breaks and poly(ADP-ribose) synthetase in pancreatic islets.
Yamamoto H; Uchigata Y; Okamoto H
Nature; 1981 Nov; 294(5838):284-6. PubMed ID: 6272129
[No Abstract] [Full Text] [Related]
5. Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis.
Uchigata Y; Yamamoto H; Kawamura A; Okamoto H
J Biol Chem; 1982 Jun; 257(11):6084-8. PubMed ID: 6281256
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
Radons J; Heller B; Bürkle A; Hartmann B; Rodriguez ML; Kröncke KD; Burkart V; Kolb H
Biochem Biophys Res Commun; 1994 Mar; 199(3):1270-7. PubMed ID: 8147870
[TBL] [Abstract][Full Text] [Related]
7. Effect of poly(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis.
Uchigata Y; Yamamoto H; Nagai H; Okamoto H
Diabetes; 1983 Apr; 32(4):316-8. PubMed ID: 6299867
[TBL] [Abstract][Full Text] [Related]
8. Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets.
Yamamoto H; Okamoto H
Biochem Biophys Res Commun; 1980 Jul; 95(1):474-81. PubMed ID: 6251809
[No Abstract] [Full Text] [Related]
9. Effects of environmental factors on the development of insulin-dependent diabetes mellitus.
Yoon JW; Kim CJ; Pak CY; McArthur RG
Clin Invest Med; 1987 Sep; 10(5):457-69. PubMed ID: 3315367
[TBL] [Abstract][Full Text] [Related]
10. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide.
Strandell E; Eizirik DL; Sandler S
Exp Clin Endocrinol; 1989 May; 93(2-3):219-24. PubMed ID: 2528468
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin.
Burkart V; Wang ZQ; Radons J; Heller B; Herceg Z; Stingl L; Wagner EF; Kolb H
Nat Med; 1999 Mar; 5(3):314-9. PubMed ID: 10086388
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells.
Berger NA; Sims JL; Catino DM; Berger SJ
Princess Takamatsu Symp; 1983; 13():219-26. PubMed ID: 6317637
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) synthetase inhibitors enhance streptozotocin-induced killing of insulinoma cells by inhibiting the repair of DNA strand breaks.
Yamamoto H; Okamoto H
FEBS Lett; 1982 Aug; 145(2):298-302. PubMed ID: 6290270
[No Abstract] [Full Text] [Related]
14. Temperature sensitivity of poly(ADP-ribose) synthetase in intact cells.
Kidwell WR; Purnell MR
Princess Takamatsu Symp; 1983; 13():243-52. PubMed ID: 6317639
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) in the cellular response to DNA damage.
Berger NA
Radiat Res; 1985 Jan; 101(1):4-15. PubMed ID: 3155867
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
Anderson T; Schein PS; McMenamin MG; Cooney DA
J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
[TBL] [Abstract][Full Text] [Related]
17. Streptozotocin-induced impairment of islet B-cell metabolism and its prevention by a hydroxyl radical scavenger and inhibitors of poly(ADP-ribose) synthetase.
Sandler S; Welsh M; Andersson A
Acta Pharmacol Toxicol (Copenh); 1983 Nov; 53(5):392-400. PubMed ID: 6318515
[TBL] [Abstract][Full Text] [Related]
18. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity in vivo and in vitro.
Masiello P; Novelli M; Fierabracci V; Bergamini E
Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):17-32. PubMed ID: 2145620
[TBL] [Abstract][Full Text] [Related]
19. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
20. DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.
Sandler S; Swenne I
Diabetes Res; 1985 Sep; 2(5):255-8. PubMed ID: 2933209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
